U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
104161104161Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME)CompletedNo Results AvailableDiabetic Retinopathy|Macular EdemaProcedure: Triple therapy of vitrectomy, IVTA and grid/focal laser photocoagulationhttps://ClinicalTrials.gov/show/NCT01202461
104162104162Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell LymphomaCompletedNo Results AvailableDiffuse Large B-cell LymphomaProcedure: CSF analysishttps://ClinicalTrials.gov/show/NCT01202448
104163104163An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin CapsuleCompletedNo Results AvailableHealthyDrug: Pregabalin controlled release, 82.5 mg|Drug: Pregabalin immediate release, 25 mghttps://ClinicalTrials.gov/show/NCT01202435
104164104164An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin CapsuleCompletedNo Results AvailableHealthyDrug: Pregabalin controlled release, 165 mg|Drug: Pregabalin controlled release, 330 mg|Drug: Pregabalin immediate release, 150 mghttps://ClinicalTrials.gov/show/NCT01202422
104165104165CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of VaterRecruitingNo Results AvailableGastrointestinal CancerDrug: Panitumumabhttps://ClinicalTrials.gov/show/NCT01202409
104166104166The Interaction Between Intestinal Microbiota, Innate Defense and Epithelial Integrity in the Development of PouchitisNot yet recruitingNo Results AvailablePouchitishttps://ClinicalTrials.gov/show/NCT01202396
104167104167Double-blinded Trial of Household-based Chlorination in IndiaCompletedNo Results AvailableDiarrhoeaBehavioral: Household-based water treatment with NADCC tablets|Behavioral: Household-based water treatment with placebo tabletshttps://ClinicalTrials.gov/show/NCT01202383
104168104168A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid MalignanciesCompletedNo Results AvailableSolid MalignanciesDrug: 7-t-butyldimethylsilyl-10-hydroxycamptothecinhttps://ClinicalTrials.gov/show/NCT01202370
104169104169Optimal Duration of Early Intervention for PsychosisNot yet recruitingNo Results AvailablePsychotic DisordersBehavioral: Community Case Managementhttps://ClinicalTrials.gov/show/NCT01202357
104170104170Computer Prediction of Restenosis Following Peripheral AngioplastyRecruitingNo Results AvailablePeripheral AngioplastyOther: Additional x-ray imageshttps://ClinicalTrials.gov/show/NCT01202344
104171104171Tripartite International Research for the Elimination of TrachomaCompletedNo Results AvailableTrachoma|ChlamydiaDrug: mass treatment with oral azithromycinhttps://ClinicalTrials.gov/show/NCT01202331
104172104172Comparative Evaluation of Stroke Triage Algorithms for Emergency Medical DispatchersWithdrawnNo Results AvailableStrokehttps://ClinicalTrials.gov/show/NCT01202318
104173104173The Use of Lymph Node Biopsies to Support HIV Pathogenesis StudiesRecruitingNo Results AvailableHIVProcedure: Lymph node biopsyhttps://ClinicalTrials.gov/show/NCT01202305
104174104174Group Motivational Intervention in Overweight/Obese Patients.RecruitingNo Results AvailableOverweight|ObesityBehavioral: Behavioral (e.g., Psychotherapy, Lifestyle Counseling)https://ClinicalTrials.gov/show/NCT01202292
104175104175Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTICompletedHas ResultsAcute Upper Respiratory Track InfectionDrug: Guaifenesin|Device: Placebohttps://ClinicalTrials.gov/show/NCT01202279
104176104176A Multiple Dose Study Of PF-05161704 In Healthy VolunteersTerminatedNo Results AvailableDiabetes Mellitus, Type 2Drug: PF-05161704 or Placebo|Drug: PF-05161704 or Placebo|Drug: PF-05161704 or Placebo|Drug: PF-05161704 or Placebo|Drug: PF-05161704 or Placebo|Drug: PF-05161704 or Placebo|Drug: PF-05161704 or Placebo|Drug: PF-05161704 or Placebohttps://ClinicalTrials.gov/show/NCT01202266
104177104177Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United KingdomCompletedHas ResultsCandidiasisDrug: anidulafunginhttps://ClinicalTrials.gov/show/NCT01202253
104178104178Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Tasocitinib (CP-690,55) plus Ketoconazolehttps://ClinicalTrials.gov/show/NCT01202240
104179104179An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic PainCompletedHas ResultsSpinal Cord Diseases|Spinal Cord Injuries|Neuralgia|PainDrug: pregabalinhttps://ClinicalTrials.gov/show/NCT01202227
104180104180Repeat Dose Safety Study for Compound to Treat AsthmaCompletedNo Results AvailableAsthmaDrug: 1440115|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01202214
104181104181A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in JapanCompletedNo Results AvailableNosocomial Rotavirus Gastroenteritis|Viral Gastroenteritis Due to RotavirusOther: Database analysishttps://ClinicalTrials.gov/show/NCT01202201
104182104182A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedHas ResultsChronic Obstructive Pulmonary Disease (COPD)Drug: indacaterol and glycopyrronium (QVA149)|Drug: glycopyrronium (NVA237)|Drug: indacaterol (QAB149)|Drug: tiotropium|Drug: placebohttps://ClinicalTrials.gov/show/NCT01202188
104183104183Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of HypertensionCompletedNo Results AvailablePre-hypertension|HypertensionDrug: Nebivololhttps://ClinicalTrials.gov/show/NCT01202175
104184104184A Comparison of Desflurane vs. Sevoflurane and the Time to Awakening and the Incidence and Severity of CoughCompletedHas ResultsSurgery|AnesthesiaDrug: Desflurane|Drug: Administration of Sevofluranehttps://ClinicalTrials.gov/show/NCT01202162
104185104185Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic DermatitisCompletedNo Results AvailableEczema|Atopic DermatitisDevice: Elidel (pimecrolimus cream, 1%) Hylatopic Plus Emollient Foam (non-medicated device)https://ClinicalTrials.gov/show/NCT01202149
104186104186The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts StudyActive, not recruitingNo Results AvailablePancreatic Cysts|Pancreatic Cancerhttps://ClinicalTrials.gov/show/NCT01202136
104187104187Post Marketing Surveillance of MENOPURCompletedNo Results AvailableInfertilityhttps://ClinicalTrials.gov/show/NCT01202123
104188104188Early Propranolol After Traumatic Brain Injury: Phase IIRecruitingNo Results AvailableTraumatic Brain InjuryDrug: Propranololhttps://ClinicalTrials.gov/show/NCT01202110
104189104189A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients With AsthmaCompletedNo Results AvailableAsthmaDrug: Salmeterol/Fluticasone|Drug: Seretidehttps://ClinicalTrials.gov/show/NCT01202097
104190104190A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma PatientsCompletedNo Results AvailableAsthmaDrug: Formoterol/Fluticasone|Drug: Foraseq®|Drug: Fluticasonehttps://ClinicalTrials.gov/show/NCT01202084

* Görseller ve İçerik tekif hakkına sahip olabilir